rs796052053
Variant summary
Our verdict is Likely pathogenic. Variant got 9 ACMG points: 10P and 1B. PM2PP5_Very_StrongBP4
The NM_003849.4(SUCLG1):c.40A>T(p.Met14Leu) variant causes a missense change. The variant allele was found at a frequency of 0.00000858 in 1,398,350 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_003849.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_pathogenic. Variant got 9 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000586 AC: 9AN: 153666Hom.: 0 AF XY: 0.0000491 AC XY: 4AN XY: 81412
GnomAD4 exome AF: 0.00000858 AC: 12AN: 1398350Hom.: 0 Cov.: 31 AF XY: 0.00000725 AC XY: 5AN XY: 689700
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Mitochondrial DNA depletion syndrome 9 Pathogenic:3
The variant is observed at an extremely low frequency in the gnomAD v2.1.1 dataset (total allele frequency: 0.006%). Predicted Consequence/Location: Missense variant Functional studies provide strong evidence of the variant having a damaging effect on the gene or gene product (PMID: 27484306). Same nucleotide change resulting in same amino acid change has been previously reported to be associated with SUCLG1-related disorder (PMID: 20453710). A different missense change at the same codon (p.Met14Thr) has been reported to be associated with SUCLG1-related disorder (ClinVar ID: VCV000632366 /PMID: 21639866). Therefore, this variant is classified as Likely pathogenic according to the recommendation of ACMG/AMP guideline. -
This variant has been previously reported as disease-causing and was found once in our laboratory with a missense variant [Q212R - phase not determined, but mother carried M14L and not Q212R] in a 7-year-old female with bilateral hearing loss and congenital chorea. Heterozygotes for this variant are expected to be asymptomatic carriers. -
This sequence change replaces methionine, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 14 of the SUCLG1 protein (p.Met14Leu). This variant is present in population databases (no rsID available, gnomAD 0.04%). This missense change has been observed in individual(s) with mitochondrial DNA depletion syndrome and/or SUCLG1-related conditions (PMID: 20453710, 27484306; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 561158). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) has been performed at Invitae for this missense variant, however the output from this modeling did not meet the statistical confidence thresholds required to predict the impact of this variant on SUCLG1 protein function. Studies have shown that this missense change alters SUCLG1 gene expression (PMID: 27484306). This variant disrupts the p.Met14 amino acid residue in SUCLG1. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 21639866, 29217198, 35094435). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at